Jason Politi
Chief Tech/Sci/R&D Officer presso VERVE THERAPEUTICS, INC.
Profilo
Jason Politi is currently the Chief Technical Operations Officer at Verve Therapeutics, Inc. Prior to his current position, he held the role of Senior Director-Clinical Manufacturing at Alexion Pharmaceuticals, Inc. and Senior Vice President-Technical Operations at Prevail Therapeutics, Inc. Mr. Politi completed his undergraduate degree at Massachusetts Institute of Technology and holds an MBA from Boston College.
Posizioni attive di Jason Politi
| Società | Posizione | Inizio |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2021 |
Precedenti posizioni note di Jason Politi
| Società | Posizione | Fine |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PREVAIL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Jason Politi
| Massachusetts Institute of Technology | Undergraduate Degree |
| Boston College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Jason Politi
